Effectiveness of Advanced Practice Nurse-Led Telehealth on Readmissions
ALTRA
2 other identifiers
interventional
300
1 country
1
Brief Summary
Aim. To develop and examine the effectiveness of an APN-led telehealth rehabilitative programme as a transitional nursing therapeutic on readmission rates and health related outcomes amongst patients with Acute Myocardial Infarction (AMI) post discharge. Design. Randomized controlled trial with repeated measures. Methodology. A consecutive sampling of 172 patients with AMI will be recruited from a tertiary hospital in Singapore. Participants will be randomised into two groups. The experimental group (ALTRA) will receive APN-led telehealth rehabilitative programme upon discharge in addition to standard care. The control group will receive only standard follow-up care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2015
CompletedFirst Posted
Study publicly available on registry
June 29, 2015
CompletedStudy Start
First participant enrolled
July 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedAugust 4, 2017
August 1, 2017
3 years
June 23, 2015
August 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Readmissions Days
Cardiac and non-cardiac causes Readmission days per 1000 follow up days will be calculated using the total number of sample in that arm x follow days (i.e. 30 days in this instance) as the denominator. (Please refer to references attached)
30 days
Secondary Outcomes (6)
Readmissions Days Per 1000 follow up days
6 months
ED visits or unplanned self-reported doctor visits
6 months
Cardiac Self-Efficacy Scale
6 months
Myocardial Infarction Dimension Assessment Scale
6 months
EuroQoL
6 months
- +1 more secondary outcomes
Study Arms (2)
APN-led Telemedicine
EXPERIMENTALParticipants will receive APN-led Telemedicine in addition to usual care.
Usual care
NO INTERVENTIONParticipants will receive the standard of care which includes education by cardiac care nurses and face-to-face consultations.
Interventions
Allocation to experimental or Usual care is 1:1. The four study APNs will be delivering the care and have at least three years working experiences in coronary care settings. A telephonic script and study protocol is made available to ensure standardization of intervention.
Eligibility Criteria
You may qualify if:
- Typical history of ischemic chest pain or angina equivalent symptoms (e.g. acute onset dyspnea)\> 30 minutes
- Undergone PCI for index event
- NT-Pro-BNP ≥1000 ng/L
- Cinically diagnosed AMI at high risk of ventricular remodeling (STEMI or NSTEMI):
- (Anterior or large inferior STEMI)
- ECG changes\>0.1mV ST segment elevation in two or more contiguous limb leads or precordial leads or
- Presence of pathological Q waves in two or more contiguous limb leads or precordial leads.
- Typical rise or fall of cardiac enzymes (cardiac troponin value exceeding the 99th percentile).
- Angiographic findings of proximal/mid LAD, proximal LCX or RCA occlusion for STEMI.
- (Or NSTEMI with)
- Typical rise or fall of cardiac enzymes (cTn value exceeding the 99th percentile).
- Peak cTnI should be \>10ug/L, TnT-hs\>250 ng/L or CK-MB \>80 IU/L
- LVEF (echocardiography) ≤ 40% or Kilip class ≥2
You may not qualify if:
- Hypersensitivity to ticagrelor, aspirin or any excipients
- Active pathological bleeding
- History of intracranial haemorrhage
- Infection within 6 weeks preceding the primary angioplasty, inflammatory disorders, Hepatitis, HIV, autoimmune disease or on immunosuppressive therapy
- Women of childbearing potential, known to be pregnant, breast-feeding, or intend to become pregnant during the study period.
- History of non-ischaemic cardiomyopathy or malignancy
- History of significant valvular heart disease (moderate or severe MS, MR, AS, AR, TR)
- Planned CABG within the next 6 weeks
- Cardiogenic shock unable to be weaned off inotropes or IABP
- Asthma or any other contraindications to beta-blockers
- Arrhythmias precluding proper CMR image acquisition, including atrial fibrillation and frequent atrial or ventricular ectopy of \> 1 in 5 intrinsic ECG complexes
- Contraindications to cardiac magnetic resonance imaging including claustrophobia, pacemaker or ICD implantation, mechanical valve or other metallic implants
- Significant liver impairment
- Renal impairment (eGFR\<45 ml min -1), end stage renal failure on renal replacement therapy
- Anaemia (Hb\<10 g/dL)
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University Hospital
Kent Ridge, 117597, Singapore
Related Publications (2)
Young W, Rewa G, Goodman SG, Jaglal SB, Cash L, Lefkowitz C, Coyte PC. Evaluation of a community-based inner-city disease management program for postmyocardial infarction patients: a randomized controlled trial. CMAJ. 2003 Oct 28;169(9):905-10.
PMID: 14581307BACKGROUNDKoh KW, Wang W, Richards AM, Chan MY, Cheng KK. Effectiveness of advanced practice nurse-led telehealth on readmissions and health-related outcomes among patients with post-acute myocardial infarction: ALTRA Study Protocol. J Adv Nurs. 2016 Jun;72(6):1357-67. doi: 10.1111/jan.12933. Epub 2016 Feb 25.
PMID: 26915719DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karen Koh
National University Heart Centre, Singapore
- STUDY CHAIR
A Mark Richards
National University Heart Centre, Singapore
- PRINCIPAL INVESTIGATOR
Mark Chan
National University Heart Centre, Singapore
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Director of Nursing
Study Record Dates
First Submitted
June 23, 2015
First Posted
June 29, 2015
Study Start
July 8, 2015
Primary Completion
June 30, 2018
Study Completion
June 30, 2018
Last Updated
August 4, 2017
Record last verified: 2017-08